Thomas JOUVE

Professor

Centre Hospitalier Universitaire Vaudois

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas JOUVE is a Professor at the Centre Hospitalier Universitaire Grenoble Alpes in France. His research focuses on kidney transplantation, particularly quality of life post-transplant, morbidity factors in elderly recipients, and the management of rejection-associated conditions. He has contributed to advancing clinical practices through studies on immunosuppressive therapies, adverse drug events, and innovative approaches to transplant care.

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Oriol Bestard

Chief of department

Hospital Universitari Vall d'Hebron

SPAIN

View details

Lionel rostaing

Chairman, Prof

Université Grenoble Alpes

FRANCE

View details

Francesc Moreso

Profesor Agregado

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas JOUVE

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Life beyond antibodies: quality of life after desensitization in kidney transplantation

Expression of Rejection-Associated Transcripts in Early Protocol Renal Transplant Biopsies Is Associated with Tacrolimus Exposure and Graft Outcome

Calcium-Free Dialysate Hemodialysis: A Simplified Approach

Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review

Unraveling complexity: morbidity factors in elderly kidney transplant recipients

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study

Adverse Drug Events after Kidney Transplantation

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study

Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study

Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates

Kidney Transplantation for Focal Segmental Glomerulosclerosis: Can We Prevent Its Recurrence? Personal Experience and Literature Review

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review

Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant Survival

How to improve clotting factors depletion in double‐filtration plasmapheresis

Collaborators (3)

Oriol Bestard

Lionel rostaing

Francesc Moreso

Make your next move.